Bath & Body Works (NYSE:BBWI) Updates Q1 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 0.360-0.430 for the period, compared to the consensus estimate of 0.440. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Bath & Body Works also updated its FY 2025 guidance to 3.250-3.600 EPS.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $41.04 on Thursday. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The stock has a market cap of $8.89 billion, a price-to-earnings ratio of 10.01, a price-to-earnings-growth ratio of 0.92 and a beta of 1.83. The stock has a 50 day moving average price of $37.82 and a 200-day moving average price of $34.07.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm’s revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.48 EPS. Sell-side analysts predict that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Investors of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 1.95%. Bath & Body Works’s payout ratio is currently 19.51%.

Analyst Ratings Changes

Several equities analysts recently issued reports on BBWI shares. Telsey Advisory Group reissued an “outperform” rating and set a $43.00 price objective on shares of Bath & Body Works in a report on Thursday, February 20th. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $42.00 to $48.00 in a report on Friday, January 10th. Cowen reiterated a “buy” rating on shares of Bath & Body Works in a research note on Thursday. TD Cowen boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, JPMorgan Chase & Co. raised shares of Bath & Body Works from a “neutral” rating to an “overweight” rating and lifted their price target for the stock from $41.00 to $47.00 in a report on Tuesday, February 18th. Six equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average price target of $44.44.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.